Home Ingredients UniK2® (Vitamin K2 as MK-7 from Natto — IFF)
Bone Health

UniK2® (Vitamin K2 as MK-7 from Natto — IFF)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

UniK2® is a natural vitamin K2 in the menaquinone-7 (MK-7) form, derived from natto, the fermented soy food. Vitamin K2 is used by the body to activate proteins involved in handling calcium. The single study cited on this page is a three year trial of generic MK-7 in postmenopausal women that measured bone only, so no heart or artery benefit is supported here, and no trial of the UniK2 brand itself is cited.

Studied Dose MK-7 is commonly sold at 45 to 180 mcg a day. The only trial cited on this page used 180 mcg a day for three years; lower doses were not tested in that study.
Active Compound Vitamin K2 as menaquinone-7 (MK-7) from natto fermentation.

Benefits

Bone strength

In a three year randomized, placebo controlled trial in 244 healthy postmenopausal women, 180 mcg of MK-7 a day improved vitamin K status and slowed the age related decline in bone mineral content and density at the lumbar spine and femoral neck. There was no significant effect at the total hip. The trial tested generic MK-7 rather than the UniK2 brand, and the authors cautioned that the results may not carry over to men or children.

Supported by Trial 1

Artery biology, not tested on this page

Vitamin K2 activates matrix Gla protein, which in laboratory work helps limit calcium deposits in artery walls. That is background biology, not a demonstrated result: the one study cited on this page looked at bone density and did not measure arteries, blood vessel stiffness or any heart outcome.

Supported by Trial 1

How MK-7 works with calcium

MK-7 activates osteocalcin, the protein that binds calcium into the bone matrix. Whether supplementing changes where calcium ends up in the body is not something the single trial cited here tested; that trial measured bone density and content only.

Supported by Trial 1

Mechanism of action

1

Osteocalcin activation

MK-7 carboxylates (activates) osteocalcin, the protein that binds calcium into the bone matrix.

2

Matrix Gla protein activation

MK-7 activates matrix Gla protein, which in laboratory research limits calcium deposition in artery walls. No study cited on this page tested this outcome in people.

Clinical trials

1
Generic MK-7 and Bone Loss: 3 Year RCT
PubMed

Three year randomized, placebo controlled trial giving 180 mcg a day of generic menaquinone-7 to 244 healthy postmenopausal women. The product tested was not UniK2 and no brand was named in the paper. (Knapen et al. 2013, Osteoporosis International)

244 healthy postmenopausal women; men and children were not studied.

MK-7 improved vitamin K status and slowed the age related loss of bone mineral content and density at the lumbar spine and femoral neck compared with placebo. There was no significant effect at the total hip.

Side effects and drug interactions

Common Potential side effects

Reported as well tolerated in the three year trial cited here, which enrolled only healthy postmenopausal women; tolerability was not tested in men or children.
Vitamin K2 interferes with warfarin-type blood thinners; do not use without medical supervision.
Mild digestive upset is occasionally reported.

Important Drug interactions

Warfarin and other vitamin-K-antagonists — directly opposes these blood thinners; medical supervision required.
No other drug interactions are described on this page; ask your pharmacist about your own medicines before starting.
Tell your doctor if you take anticoagulants.

More Bone Health Ingredients

Bone Health
Calcium
Calcium is the most abundant mineral in the body — about 99% stored in bones and teeth, wi…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Bone Health
Vitamin K
Vitamin K is a fat-soluble vitamin essential for blood clotting and for directing calcium…
Bone Health
Copper
Copper is an essential trace mineral that a number of enzymes need in order to work, inclu…

Explore Other Ingredients

Cardiovascular
Beetroot
Beetroot is a vegetable rich in dietary nitrate, which the body converts into nitric oxide…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Athletic Performance
L-Carnitine
L-Carnitine is a naturally-occurring amino acid derivative essential for fatty acid metabo…

Frequently asked questions about UniK2® (Vitamin K2 as MK-7 from Natto — IFF)

What is UniK2?

UniK2® is a natural vitamin K2 in the menaquinone-7 (MK-7) form, derived from natto, the fermented soy food. Vitamin K2 is used by the body to activate proteins involved in handling calcium.

What is UniK2 used for?

UniK2 is researched primarily for Bone Health. In a three year randomized, placebo controlled trial in 244 healthy postmenopausal women, 180 mcg of MK-7 a day improved vitamin K status and slowed the age related decline in bone mineral content and density at the lumbar spine and femoral…

What is the recommended dosage of UniK2?

The clinically studied dose is MK-7 is commonly sold at 45 to 180 mcg a day. The only trial cited on this page used 180 mcg a day for three years; lower doses were not tested in that study. Always follow the product label and check with a healthcare provider for personal advice.

Is UniK2 safe, and does it have side effects?

For most healthy adults, UniK2 is well tolerated at studied doses. Reported effects can include: Reported as well tolerated in the three year trial cited here, which enrolled only healthy postmenopausal women; tolerability was not tested in men or children. Vitamin K2 interferes with warfarin-type blood thinners; do not use without medical supervision. It may also interact with some medications. UniK2 is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does UniK2 interact with any medications?

Possible interactions include: Warfarin and other vitamin-K-antagonists — directly opposes these blood thinners; medical supervision required. No other drug interactions are described on this page; ask your pharmacist about your own medicines before starting. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for UniK2?

NutraSmarts rates the evidence for UniK2 as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Knapen MH, Drummen NE, Smit E, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-507..PubMedUsed to support: Randomized, placebo controlled three year trial of generic MK-7 (the same nutrient used in UniK2) in 244 healthy postmenopausal women. The paper names no brand, so this is not UniK2 specific evidence, and no UniK2 trial is cited on this page. Bone endpoints only, with no significant effect at the total hip.